Aprea Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.68

-0.02 (-2.43%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +5,179.6% upside

Low Target $23.45

Average Target $36.06

High Target $38.88

Current Price $0.68

Current
$0.68

Target
$36.06

$23.45 $36.06 avg $38.88

Scenario Analysis

Bear Case

$23.45

3,333.4%

Low target

Base Case

$36.06

+5,179.6%

Avg target

Bull Case

$38.88

+5,592.5%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$2.34

-70.8% from high

52-Week Low

$0.55

+24.6% from low

Target vs 52W High

$36.06

+1,442.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+18.4%
AMGN Amgen Inc	Hold	42	50%	$190.87	-45.8%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+160.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-1.8%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.1%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-28.5%